Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Clinical trial NCT05114746 · COMPLETED

Trial details

NCT number: NCT05114746
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2022-01-25
Primary completion: 2023-12-08
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.